For more than 25 years, McGill professor Yann Joly has worked at the intersection of law, genetics and ethics. He has won the 2026 Acfas Jacques-Rousseau Prize for research that has helped shape how genetic data is shared, used and protected. The award recognizes excellence in multidisciplinary research.
In its Nov. 19 press release, Acfas highlighted Joly’s work developing safeguards for genomic data, studying genetic discrimination and integrating legal and ethical perspectives into biomedical research.
“He has demonstrated exceptional intellectual and institutional leadership, profoundly reshaping multidisciplinary research in genomics, law and bioethics in Quebec while raising its profile on the international stage,” the organization said.
For Joly, the award is welcome recognition for an approach that can be difficult to pursue in universities traditionally organized around the traditional separation of expertise in distinct departments and faculties.
“Multidisciplinarity sounds good, and everyone encourages it,” he said. “But it can be surprisingly difficult to get funding for multidisciplinary initiatives and to find your place within a university.”
How genetics shaped his work
Joly studied law at the Université de Montréal and was admitted to the Quebec Bar in 2003. He joined McGill’s Department of Human Genetics as an assistant professor in 2009, examining the legal, ethical and policy questions raised by genetic research.

“I felt constrained in an education system that pushes you to make decisions about your future very early. I didn’t want to be limited to one field,” he said. “The researcher and curious person in me wanted to work in a field that was evolving rapidly. Genetics was the perfect fit.”
Joly played a key role in the International Cancer Genome Consortium, which brought together researchers from 18 countries. Beginning in 2009, he chaired the consortium’s data-access committee and later led its Ethics and Governance Committee while also sitting in its Scientific Steering Committee.
He helped develop an early controlled-access model that allowed sensitive genetic data to be shared while protecting confidentiality and negotiated the first contractual clauses to store health data in the cloud.
“I’m proud that the controlled-access model has stood the test of time,” Joly said. “Most of the databases operating today still use some form of controlled access.”
Balancing data sharing with privacy remains difficult, particularly as technology evolves.
“We live in an era of the internet, cellphones and AI,” Joly said. “Protecting confidentiality and privacy while sharing data is extremely difficult. It’s a moving target: you build a system that you think provides reasonable protection, but six months later, you may need to review and change it.”
Protecting data, preventing discrimination
In 2018, Joly founded the Genetic Discrimination Observatory, a network of experts in more than 30 countries studying genetic discrimination and policy responses. He has also advised on the constitutionality of Canada’s Genetic Non-Discrimination Act and how laws can address emerging risks.
As director of McGill’s Centre of Genomic Policy, Joly has studied genetic discrimination affecting vulnerable populations, including intersex people. Last year, the centre and Intersex Canada collaborated on Towards Affirmative Communication in Intersex Health in Canada, a first-of-its-kind guide designed to help health professionals improve care for intersex people.
Joly sees similar accountability challenges in health-care’s growing use of AI to predict disease risk and patients’ responses to medication.
“If we don’t impose requirements for transparency and explainability – if we don’t know what information went into a model in the first place – we may eventually reach a point where nobody can explain how it works or why it produces a particular result,” he said.
Lessons from COVID-19
During the COVID-19 pandemic, Joly led the committee overseeing access to genetic data collected by Canadian researchers and public health agencies through Genome Canada’s CanCOGeN network.
The work highlighted the challenge of protecting personal information while enabling research. Joly said the pandemic also exposed misconceptions about the limits of privacy protections.
“During a pandemic, the balance shifts,” he said. “Individual privacy may carry somewhat less weight, while our collective responsibility to protect public health becomes more pressing. That doesn’t mean abandoning privacy altogether, but it does mean that reasonable compromises sometimes have to be reached.”
Advice for young researchers
For early-career researchers interested in multidisciplinary work, Joly emphasizes the importance of collaboration and humility.
“It’s about bringing together people from different disciplines who can work collaboratively, contribute their respective expertise and integrate their efforts into something greater than the sum of its parts,” he said.
After years of working with geneticists, Joly knows that learning across disciplines also means recognizing what lies beyond your expertise.
“I’m never going to know genetics as well as a geneticist, and I don’t expect that of myself,” he said. “You learn a tremendous amount, but you also have to recognize that more complex technical concepts fall outside your capacity to truly master.”